1.
Alnylam Pharmaceuticals
2002
2.
Arrowhead Pharmaceuticals
1989
3.
BioNTech
4.
CureVac
2000
5.
Elicio Therapeutics
2011
6.
eTheRNA
12.
Personalis
2011
13.
Providence Therapeutics
2015
14.
RNAimmune
2020
15.
Sorrento Therapeutics
2006
16.
Vaccitech
2016
«Cancer Vaccine Industry Q3 2022 - By Vector»
- — organisation
- — investor and funding support bodies
- — hubs and other organisation types
Industries
© 2026